6-butylamino-nicotinic acid | 858431-45-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 6-butylamino-nicotinic acid
• 英文别名: 6-Butylamino-nicotinsaeure；6-(Butylamino)nicotinic acid；6-(butylamino)pyridine-3-carboxylic acid
• CAS: 858431-45-5
• 化学式: C₁₀H₁₄N₂O₂
• 分子量: 194.233
• InChiKey: AABHMQVNLULEDP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  62.2
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  6-butylamino-nicotinic acid 在 盐酸 作用下， 生成 ethyl 6-(butylamino)nicotinate
  参考文献：
  名称：

  Esters of aminopyridine carboxylic acid and processes for producing the same

  摘要：

  公开号：

  US02194567A1
• 作为产物：
  描述：

  6-氯烟酸 、 正丁胺 以 异丙醇 为溶剂， 反应 0.67h， 以4%的产率得到6-butylamino-nicotinic acid
  参考文献：
  名称：

  3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b

  摘要：

  A series of 3-nitro-4-substituted-aminobenzoic acids were prepared and found to act as potent and highly selective agonists of the orphan human GPCR GPR109b, a low affinity receptor for niacin. No activity was observed at the closely homologous high affinity niacin receptor, GPR109a. A second series, comprising 6-amino-substituted nicotinic acids was, also prepared and several analogues showed comparable activity to the nitroaryl series. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.09.058

文献信息

• COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR
  申请人：Arvinas Operations, Inc.

  公开号：EP3660004A1

  公开（公告）日：2020-06-03

  The present disclosure relates to bifunctional compounds, which find utility to degrade and (inhibit) Androgen Receptor. In particular, the present disclosure is directed to compounds, which contain on one end a cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds Androgen Receptor, such that Androgen Receptor is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of Androgen Receptor. The present disclosure exhibits a broad range of pharmacological activities associated with compounds according to the present disclosure, consistent with the degradation/inhibition of Androgen Receptor.

  本公开涉及双功能化合物，它们可用于降解和（抑制）雄激素受体。特别是，本公开涉及的化合物一端含有与 E3 泛素连接酶结合的脑龙配体，另一端含有与雄激素受体结合的分子，这样雄激素受体就被置于泛素连接酶附近，从而实现对雄激素受体的降解（和抑制）。本公开的化合物具有广泛的药理活性，与雄激素受体的降解/抑制作用相一致。
• DE743467
  申请人：——

  公开号：——

  公开（公告）日：——
• 3-Nitro-4-amino benzoic acids and 6-amino nicotinic acids are highly selective agonists of GPR109b
  作者：Philip J. Skinner、Martin C. Cherrier、Peter J. Webb、Carleton R. Sage、Huong T. Dang、Cameron C. Pride、Ruoping Chen、Susan Y. Tamura、Jeremy G. Richman、Daniel T. Connolly、Graeme Semple

  DOI：10.1016/j.bmcl.2007.09.058

  日期：2007.12

  A series of 3-nitro-4-substituted-aminobenzoic acids were prepared and found to act as potent and highly selective agonists of the orphan human GPCR GPR109b, a low affinity receptor for niacin. No activity was observed at the closely homologous high affinity niacin receptor, GPR109a. A second series, comprising 6-amino-substituted nicotinic acids was, also prepared and several analogues showed comparable activity to the nitroaryl series. (c) 2007 Elsevier Ltd. All rights reserved.
• Esters of aminopyridine carboxylic acid and processes for producing the same
  申请人：PYRIDIUM CORP

  公开号：US02194567A1

  公开（公告）日：1940-03-26